Russell Investments Group
MBIO icon

Russell Investments Group’s Mustang Bio MBIO Stock Holding History

Russell Investments Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-589
Closed -$1.19M – 3059
2021
Q3 		$1.19M Buy
+589
New +$1.27M ﹤0.01% 2112
2021
Q2 		– Sell
-194
Closed -$482K – 3267
2021
Q1 		$482K Sell
194
-85
-30% -$253K ﹤0.01% 2536
2020
Q4 		$791K Buy
279
+215
+336% +$514K ﹤0.01% 2224
2020
Q3 		$150K Buy
64
+56
+700% +$138K ﹤0.01% 2883
2020
Q2 		$18K Buy
+8
New +$18.7K ﹤0.01% 3061

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Russell Investments Group's MBIO Position: Q4 2021 in Review

Russell Investments Group sold out of Mustang Bio (MBIO) in Q4 2021, closing a stake of 589 shares — an estimated $1.19M sold.

Russell Investments Group first reported a position in MBIO in Q2 2020 and held it in 5 quarters. The position peaked at $1.19M in Q3 2021. 83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

  • Russell Investments Group reported no remaining Mustang Bio position as of Q4 2021 after selling out during the quarter.
  • Russell Investments Group sold 589 Mustang Bio shares in Q4 2021, an estimated $1.19M.
  • Russell Investments Group first reported a position in Mustang Bio in Q2 2020 and held it in 5 quarters.
  • Russell Investments Group's Mustang Bio position peaked at $1.19M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.